Vimarsana
Biggest News Aggregation in the World

Page 17 - Alacyclovir News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alacyclovir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alacyclovir Today - Breaking & Trending Today

Few HIV Patients Treated for Hep C Given Contraindicated HIV Drugs - Vimarsana News

Few HIV Patients Treated for Hep C Given Contraindicated HIV Drugs

Few people who are co-infected with HCV and HIV and are being treated with direct-acting antivirals also receive contraindicated antiretrovirals, European researchers report.

FDA Asks Pfizer to Test Second Paxlovid Course in Patients With COVID Rebound - Vimarsana News

FDA Asks Pfizer to Test Second Paxlovid Course in Patients With COVID Rebound

The U.S. Food and Drug Administration (FDA) has asked Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment, the regulator said on Friday.

Convalescent Plasma Not Advised for Most Hospitalized With COVID - Vimarsana News

Convalescent Plasma Not Advised for Most Hospitalized With COVID

“CCP is most effective when transfused with high neutralizing titers early after symptom onset.”

US Tops 10,000 Confirmed Monkeypox Cases: CDC - Vimarsana News

US Tops 10,000 Confirmed Monkeypox Cases: CDC

Monkeypox cases have been found in every state except Wyoming.

Xofluza Approved for Treating Flu in Children - Vimarsana News

Xofluza Approved for Treating Flu in Children

An antiviral medication that's been treating adults with influenza for years now has an application for children.